Citation Formats
Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

R. N. Tandogan Et Al. , "Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial," Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2, pp.519-528, 2021

Tandogan, R. N. Et Al. 2021. Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2 , 519-528.

Tandogan, R. N., Polat, M., Beyzadeoglu, T., KARABULUT, E., Yildirim, K., & Kayaalp, A., (2021). Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2, 519-528.

Tandogan, Reha Et Al. "Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial," Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2, 519-528, 2021

Tandogan, Reha N. Et Al. "Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial." Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2, pp.519-528, 2021

Tandogan, R. N. Et Al. (2021) . "Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial." Knee Surgery, Sports Traumatology, Arthroscopy , vol.29, no.2, pp.519-528.

@article{article, author={Reha N. Tandogan Et Al. }, title={Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial}, journal={Knee Surgery, Sports Traumatology, Arthroscopy}, year=2021, pages={519-528} }